The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...

BioNTech (BNTX) on Friday announced separate agreements with the US National Institutes of Health and the University of Pennsylvania to settle royalty claims related to sales of its COVID-19 ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

BioNTech SE has completed its acquisition of Biotheus, a clinical-stage biotechnology company focused on developing novel antibodies for cancer and inflammatory diseases. This acquisition ...

This COVID-19 vaccine remains BioNTech's primary revenue source for now. However, the company is working with Pfizer to evaluate two vaccines in late-stage testing, one for influenza and another ...

(RTTNews) - BioNTech SE (BNTX), an immunotherapy company, on Monday announced the completion of its acquisition of Biotheus, a clinical-stage biotechnology company focused on the development of ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the treatment of advanced cancers With the closing of the ...